Arabic Arabic English English French French German German
dark

AlzeCure gets Late Breaking Abstract Accepted on NeuroRestore’s Positive Effect on Mitochondrial Function

AlzeCure Pharma AB announced that an abstract on its research platform NeuroRestore in mitochondrial function has been accepted for an oral presentation at AD/PD 2022, which this year will be held in Barcelona on March 15-20. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Curebase and Persephone Biosciences Partner in Clinical Trial of Colorectal Cancer Among Diverse Populations

Next Post

SNIPR BIOME Announces FDA Clearance of Investigational New Drug (IND) Application for SNIPR001, a Novel CRISPR Therapy Targeting Life-Threatening E. coli Infections

Related Posts
Total
0
Share